1. Home
  2. ICON vs IBO Comparison

ICON vs IBO Comparison

Compare ICON & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICON
  • IBO
  • Stock Information
  • Founded
  • ICON 2023
  • IBO 2018
  • Country
  • ICON Greece
  • IBO United States
  • Employees
  • ICON N/A
  • IBO N/A
  • Industry
  • ICON
  • IBO
  • Sector
  • ICON
  • IBO
  • Exchange
  • ICON Nasdaq
  • IBO NYSE
  • Market Cap
  • ICON 5.2M
  • IBO 5.8M
  • IPO Year
  • ICON 2024
  • IBO 2024
  • Fundamental
  • Price
  • ICON $2.89
  • IBO $0.58
  • Analyst Decision
  • ICON Strong Buy
  • IBO
  • Analyst Count
  • ICON 1
  • IBO 0
  • Target Price
  • ICON $4.50
  • IBO N/A
  • AVG Volume (30 Days)
  • ICON 3.4M
  • IBO 23.4M
  • Earning Date
  • ICON 09-09-2025
  • IBO 08-23-2025
  • Dividend Yield
  • ICON 332.15%
  • IBO N/A
  • EPS Growth
  • ICON N/A
  • IBO N/A
  • EPS
  • ICON N/A
  • IBO N/A
  • Revenue
  • ICON $5,474,000.00
  • IBO N/A
  • Revenue This Year
  • ICON $51.78
  • IBO N/A
  • Revenue Next Year
  • ICON $51.90
  • IBO N/A
  • P/E Ratio
  • ICON N/A
  • IBO N/A
  • Revenue Growth
  • ICON 16.93
  • IBO N/A
  • 52 Week Low
  • ICON $1.60
  • IBO $0.36
  • 52 Week High
  • ICON $154.00
  • IBO $6.17
  • Technical
  • Relative Strength Index (RSI)
  • ICON N/A
  • IBO N/A
  • Support Level
  • ICON N/A
  • IBO N/A
  • Resistance Level
  • ICON N/A
  • IBO N/A
  • Average True Range (ATR)
  • ICON 0.00
  • IBO 0.00
  • MACD
  • ICON 0.00
  • IBO 0.00
  • Stochastic Oscillator
  • ICON 0.00
  • IBO 0.00

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Share on Social Networks: